Technical Analysis for HRMY - Harmony Biosciences Holdings, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 29.32 | 1.35% | 0.39 |
HRMY closed up 1.35 percent on Friday, April 26, 2024, on approximately normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
Earnings due: Apr 30
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Flat |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| Shooting Star Candlestick | Bearish | 0.00% | |
| Slingshot Bearish | Bearish Swing Setup | 0.00% | |
| Multiple of Ten Bearish | Other | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Hammer Candlestick | Bullish | 1.35% | |
| Lizard Bullish | Bullish Day Trade Setup | 1.35% | |
| Doji - Bullish? | Reversal | 1.35% | |
| Gapped Down | Weakness | 1.35% | |
| Oversold Stochastic | Weakness | 1.35% |
| Alert | Time |
|---|---|
| 20 DMA Resistance | about 18 hours ago |
| Up 3% | about 21 hours ago |
| Rose Above 10 DMA | about 21 hours ago |
| Up 2% | about 21 hours ago |
| Lizard Bullish Entry | about 22 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 04/30/2024
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients living with rare neurological disorders. Its lead product includes WAKIX (pitolisant) for the treatment of pediatric patients suffering from narcolepsy. Harmony Biosciences Holdings, Inc. was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. The company was founded in 2017 and is based in Plymouth Meeting, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Neurological Disorders Stage Pharmaceutical Ethers Urological Disorders Chloroarenes Narcolepsy Piperidines Rare Neurological Disorders Stimulants
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Neurological Disorders Stage Pharmaceutical Ethers Urological Disorders Chloroarenes Narcolepsy Piperidines Rare Neurological Disorders Stimulants
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 39.265 |
| 52 Week Low | 18.6112 |
| Average Volume | 402,691 |
| 200-Day Moving Average | 31.34 |
| 50-Day Moving Average | 31.40 |
| 20-Day Moving Average | 30.14 |
| 10-Day Moving Average | 29.26 |
| Average True Range | 1.29 |
| RSI (14) | 43.18 |
| ADX | 15.35 |
| +DI | 18.59 |
| -DI | 19.23 |
| Chandelier Exit (Long, 3 ATRs) | 30.21 |
| Chandelier Exit (Short, 3 ATRs) | 32.01 |
| Upper Bollinger Bands | 32.58 |
| Lower Bollinger Band | 27.69 |
| Percent B (%b) | 0.33 |
| BandWidth | 16.25 |
| MACD Line | -0.75 |
| MACD Signal Line | -0.70 |
| MACD Histogram | -0.0462 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 31.03 | ||||
| Resistance 3 (R3) | 31.11 | 30.63 | 30.75 | ||
| Resistance 2 (R2) | 30.63 | 30.19 | 30.59 | 30.65 | |
| Resistance 1 (R1) | 29.97 | 29.92 | 30.30 | 29.89 | 30.55 |
| Pivot Point | 29.49 | 29.49 | 29.65 | 29.45 | 29.49 |
| Support 1 (S1) | 28.83 | 29.05 | 29.16 | 28.75 | 28.09 |
| Support 2 (S2) | 28.35 | 28.78 | 28.31 | 27.99 | |
| Support 3 (S3) | 27.69 | 28.35 | 27.90 | ||
| Support 4 (S4) | 27.61 |
